Omega Therapeutics, Inc. Common Stock
OMGA
OMGA was delisted on the 24th of February, 2025.
58 hedge funds and large institutions have $109M invested in Omega Therapeutics, Inc. Common Stock in 2023 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 22 increasing their positions, 13 reducing their positions, and 6 closing their positions.
148% more call options, than puts
Call options by funds: $99K | Put options by funds: $40K
69% more repeat investments, than reductions
Existing positions increased: 22 | Existing positions reduced: 13
0% more funds holding
Funds holding: 58 → 58 (0)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
0% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 6
62% less capital invested
Capital invested by funds: $286M → $109M (-$177M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
+$496K |
| 2 |
Squarepoint
New York
|
+$275K |
| 3 |
State Street
Boston,
Massachusetts
|
+$184K |
| 4 |
6CM
683 Capital Management
New York
|
+$133K |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$99.9K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$962K |
| 2 |
OIM
Oracle Investment Management
Greenwich,
Connecticut
|
-$589K |
| 3 |
BlackRock
New York
|
-$319K |
| 4 |
Citigroup
New York
|
-$197K |
| 5 |
LCM
Laurion Capital Management
New York
|
-$135K |
OMGA Hedge Fund Activity: Q3 2023 in Review
58 of the 6,302 institutional investors tracked by Wall St. Rank reported a position in Omega Therapeutics, Inc. Common Stock (OMGA) for Q3 2023, worth a combined $109M — down 62% from $286M a quarter earlier.
Fund positioning in OMGA was balanced in Q3 2023: 6 funds opened new positions, 6 closed out, 22 added to existing stakes and 13 trimmed.
The largest buyer was Millennium Management, adding an estimated $496K. The largest seller was Fidelity Investments, cutting an estimated $962K.
- 58 institutional investors held Omega Therapeutics, Inc. Common Stock (OMGA) as of Q3 2023, unchanged from Q2 2023.
- Funds reported $109M of Omega Therapeutics, Inc. Common Stock stock for Q3 2023, down 62% quarter-over-quarter.
- 6 funds opened new Omega Therapeutics, Inc. Common Stock positions in Q3 2023 and 6 closed out, a net change of 0 holders.
- The largest Omega Therapeutics, Inc. Common Stock buyer in Q3 2023 was Millennium Management, an estimated $496K added.
- The largest Omega Therapeutics, Inc. Common Stock seller in Q3 2023 was Fidelity Investments, an estimated $962K sold.
Based on aggregated 13F filings for Q3 2023.